Lebwohl, M. G., J. Sugarman, D. M. Pariser, J. Bagel, C. Trickett, A. Jacobson, and R. Israel. “Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s38, doi:10.25251/skin.4.supp.38.